0.0455

8.20% -0.0045

Psyence Biomedical Ltd (PBM)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$0.05

Offen:

$0.05

24-Stunden-Volumen:

6.03M

Relative Volume:

0.90

Marktkapitalisierung:

$2.94M

Einnahmen:

Nettoeinkommen (Verlust:

KGV:

EPS:

Netto-Cashflow:

1W Leistung:

-15.00%

1M Leistung:

-60.29%

6M Leistung:

-94.59%

1J Leistung:

+0.00%

1-Tages-Spanne:

$0.044

$0.05

1-Wochen-Bereich:

$0.044

$0.058

52-Wochen-Spanne:

$0.044

$4.31

Psyence Biomedical Ltd Stock (PBM) Company Profile

Firmenname

Psyence Biomedical Ltd

Sektor

Healthcare (1195)

Branche

Biotechnology (683)

Telefon

Adresse

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

PBM's Discussions on Twitter

Vergleichen Sie PBM mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PBM	0.045	2.94M	0	0	0	0.00
VRTX	449.80	115.43B	10.63B	-479.80M	-1.35B	13.33
REGN	747.39	82.04B	13.85B	4.65B	3.32B	35.06
ARGX	593.04	35.30B	1.86B	-40.29M	-1.28B	-4.16
ALNY	246.15	32.04B	2.09B	-332.26M	16.06M	-4.14
BNTX	107.32	24.89B	3.30B	-501.07M	1.03B	11.54

Psyence Biomedical Ltd Aktie (PBM) Neueste Nachrichten

Nov 20, 2024

Psyence Biomedical Secures Extension To Meet Nasdaq Compliance Standards - Benzinga

Nov 20, 2024

Psyence Biomedical to consolidate shares in bid to keep Nasdaq listing - Green Market Report

Nov 20, 2024

Psyence Biomedical gets extension to show compliance with Nasdaq’s listing rules - MSN

Nov 20, 2024

Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing - The Manila Times

Nov 20, 2024

Psyence Biomed granted Nasdaq listing extension - Investing.com

Nov 20, 2024

Psyence Biomedical Announces Favorable Result Of Nasdaq Listing Qualifications Hearing - XM

Nov 20, 2024

Psyence Biomedical Secures Nasdaq Extension, Plans 1-for-75 Share Consolidation | PBM Stock News - StockTitan

Nov 20, 2024

Psyence Biomedical fell on 75-to-1 share consolidation and Nasdaq delisting notice - MSN

Nov 20, 2024

Nov 19, 2024

Psyence Biomed announces share consolidation date - Investing.com India

Nov 19, 2024

Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation - The Manila Times

Nov 19, 2024

Psyence Biomedical Implements 1-for-75 Share Consolidation to Meet Nasdaq Requirements | PBM Stock News - StockTitan

Nov 19, 2024

Psyence Biomed announces share consolidation date By Investing.com - Investing.com Canada

Nov 19, 2024

Nov 12, 2024

Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from Nasdaq - The Manila Times

Nov 12, 2024

Psyence Biomedical Shareholders Approve 75:1 Stock Split Amid Nasdaq Compliance Challenge | PBM Stock News - StockTitan

Nov 12, 2024

Psyence Biomedical Announces Results from Annual and - GlobeNewswire

Nov 12, 2024

Oct 31, 2024

Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabs - GlobeNewswire

Oct 31, 2024

Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs - Yahoo Finance

Oct 31, 2024

Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group's Stake in PsyLabs - The Manila Times

Oct 31, 2024

Oct 30, 2024

Where Do Analysts See Psyence Biomedical Ltd. (NASDAQ: PBM) Heading? - Stocks Register

Oct 30, 2024

Oct 26, 2024

Bullish Prospects For Psyence Biomedical Ltd. (NASDAQ: PBM) Shares In 2024 - Stocks Register

Oct 26, 2024

Oct 25, 2024

Natural Gas LDay (F) (HHM19) Quote - The Globe and Mail

Oct 25, 2024

Psyence Biomed adds Australian site for psilocybin trial - Investing.com

Oct 25, 2024

Oct 24, 2024

Psyence Biomed adds Australian site for psilocybin trial By Investing.com - Investing.com South Africa

Oct 24, 2024

Psyence Biomed Announces Recruitment of Second Clinical - GlobeNewswire

Oct 24, 2024

Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care - StockTitan

Oct 24, 2024

Oct 23, 2024

Psyence Biomedical Sets Annual General Meeting for November 12 - Investing.com

Oct 23, 2024

Psyence Biomedical Plans Key Shareholder Meeting - TipRanks

Oct 23, 2024

Psyence Biomedical Sets Annual General Meeting for November 12 By Investing.com - Investing.com UK

Oct 23, 2024

Oct 17, 2024

Psyence Biomed Provides Progress Update on PsyLabs E.U. Good Manufacturing Practices (GMP) Certified Active Pharmaceutical Ingredient (API) Development - The Manila Times

Oct 17, 2024

Oct 14, 2024